Quilostigmine
- Level
- Commodity
- Parent
- 51151500
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51151528This classification denotes an acetylcholinesterase inhibitor with the molecular formula C23H27N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2L1YNO4SQJ, chemically known as 2(1h)-isoquinolinecarboxylic acid, 3,4-dihydro-, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl ester, (3as-cis)- but generally known as quilostigmine, which bears US NIH Compound Identifier 132228. European Medicines Agency schedules Quilostigmine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10196MIG. The term QUILOSTIGMINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 3 1997, List 38). QUILOSTIGMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule quilostigmine under HS 29334990 and SITC 51575. As of Q4 2014, QUILOSTIGMINE remains the US FDA Preferred Term for this commodity. Quilostigmine bears US NLM identifiers UMLS ID C0755738 and NCI Concept Code C81922. SMILES: O(C1CC2C3(C(N(CC3)C)N(C2CC1)C)C)C(=O)N1CCC2C(C1)CCCC2.
Same parent
Under 51151500 · 44Activities that produce or sell this
KBLI · 8Inherited from family 51150000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.